Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients

PLoS One. 2014 Jan 30;9(1):e87904. doi: 10.1371/journal.pone.0087904. eCollection 2014.

Abstract

Monocarboxylate transporter 4 (MCT4) is a cell membrane transporter of lactate. Recent studies have shown that MCT4 is over-expressed in various cancers; however, its role in cancer maintenance and aggressiveness has not been fully demonstrated. This study investigated the role of MCT4 in oral squamous cell carcinoma (OSCC), and found that it is highly expressed in OSCC patients by using immunohistochemistry. Moreover, this over-expression of MCT4 was closely associated with tumor size, TNM classification, lymphatic metastasis, distant metastasis and tumor recurrence, and also poor prognosis. To further study mechanisms of MCT4 in vitro, we used small-interfering RNA to silence its expression in OSCC cell lines. The results showed that knock-down of MCT4 decreased cell proliferation, migration, and invasion. The inhibition of proliferation was associated with down-regulation of p-AKT and p-ERK1/2, while decreased cell migration and invasion may be caused by down-regulation of integrin β4-SRC-FAK and MEK-ERK signaling. Together, these findings provide new insight into the critical role of MCT4 in cell proliferation and metastasis in OSCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Cell Movement / genetics*
  • Cell Proliferation
  • Down-Regulation / genetics
  • Female
  • Humans
  • Lymphatic Metastasis / genetics
  • Lymphatic Metastasis / pathology
  • MAP Kinase Signaling System / genetics
  • Male
  • Middle Aged
  • Monocarboxylic Acid Transporters / genetics*
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / pathology
  • Muscle Proteins / genetics*
  • Neoplasm Recurrence, Local / genetics
  • Neoplasm Recurrence, Local / pathology
  • Prognosis
  • Proto-Oncogene Proteins c-akt / genetics

Substances

  • Monocarboxylic Acid Transporters
  • Muscle Proteins
  • SLC16A4 protein, human
  • Proto-Oncogene Proteins c-akt

Grants and funding

This work was supported by National Natural Science Foundation of China (NO. 81202549), National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2012ZX09301001-007), and by Priority Academic Program Development of Jiangsu Higher Education Institutions (No. jx10531801/005).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.